11 February 2021

The Marie Sklodowska-Curie fellowships are very prestigious awards from the European Commission.They support researchers at all stages of their careers, regardless of age and nationality. The MSCA also support cooperation between industry and academia and innovative training to enhance employability and career development.

Juan Pablo Rigalli, theme Renal disorders, is awarded with a Marie Curie Fellowship from the European Commission to study the application of extracellular vesicles in precision pharmacotherapy. 

Extracellular vesicles are nanoparticles released by almost every cell of the organism. They are easily accessible, for example in urine and blood, and provide useful information about the cells of origin. In the frame of this project, which will be executed at Heidelberg University Hospital (Germany), Juan will investigate the application of extracellular vesicles to estimate the drug clearance capacity of different tissues.

In general, drugs are prescribed based on average parameters from a population. However, individuals may exhibit enormous differences in their drug clearance. This could lead to the lack of therapeutic efficacy or toxicity. For some particular therapeutic agents, life threatening situations may occur due to underdosing or overdosing. Hereby, extracellular vesicles will be investigated as a potential tool to assist the physicians in providing a treatment fitted to each individual patient.

The fellowship is a Standard European Fellowship to move to Heidelberg University Hospital in Germany. In the past years, Juan and his colleagues in renal physiology (Department of Physiology) have investigated extracellular vesicles. Joost Hoenderop and Juan will continue an active collaboration to further develop this line of research.

Related news items


Large AI project receives over €95 million for ten years of public-private research

23 September 2021

Radboud university medical center (Radboudumc) participates in the ROBUST consortium, which consists of 17 AI labs, eight of which are dedicated to healthcare. Radboud university medical center leads five of these eight labs.

read more

Reading ADP-ribosylation signaling using chemical biology and interaction proteomics published in Molecular Cell

22 September 2021

Kasia Kliza and Michiel Vermeulen worked on a project to synthesize biotinylated ADPr-based probes that can identify ADPr readers and determine their specificity for mono- and polyADPr. They published this in Molecular Cell.

read more

Systematic analysis of short tandem repeats in 38,095 exomes provides an additional diagnostic yield

22 September 2021

Christian Gilissen and colleagues published in Genetics in Medicine about their work guiding the application of short tandem repeat analysis in clinical exome sequencing.

read more

TropIQ seeks new mosquito repellents

21 September 2021

TropIQ Health Sciences, a Radboudumc spin-off, has received a 1.3 million USD grant from the Bill & Melinda Gates Foundation to track down new mosquito repellents.

read more

Young Radboudumc researchers receive grant to engage in bio-medical and health research that is off the beaten path

16 September 2021

The ZonMw Off Road program is once again giving young scientists the opportunity to conduct innovative research in medical and/or health care. This research is off the beaten track and aims to bring about new insights and unexpected breakthroughs for healthcare and healthcare innovation.

read more

Infections increase risk to develop dementia

16 September 2021

In a recently published study, Radboudumc researchers investigated the effects of infectious events on cognitive decline and the development of dementia and its possible structural underpinning using pre- and post-infection MRI of the brain.

read more